Omron Corp. (OTCMKTS:OMRNY) Short Interest Update

Omron Corp. (OTCMKTS:OMRNY) was the target of a large decline in short interest in the month of February. As of February 13th, there was short interest totaling 12,759 shares, a decline of 20.9% from the January 29th total of 16,138 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 161,213 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 161,213 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

Omron Trading Down 7.2%

OTCMKTS:OMRNY opened at $31.86 on Wednesday. The firm has a market capitalization of $6.57 billion, a P/E ratio of 40.33, a PEG ratio of 0.54 and a beta of 0.92. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.11 and a quick ratio of 1.37. Omron has a one year low of $23.23 and a one year high of $35.90. The company’s 50-day simple moving average is $28.02 and its 200 day simple moving average is $27.17.

Omron (OTCMKTS:OMRNY) last released its earnings results on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.19). The business had revenue of $1.41 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Omron had a net margin of 2.80% and a return on equity of 2.46%. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. As a group, analysts forecast that Omron will post 0.42 EPS for the current fiscal year.

Institutional Trading of Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC grew its position in Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,129 shares of the company’s stock after buying an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 1.09% of the company’s stock.

Analyst Ratings Changes

Separately, Zacks Research raised Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of “Hold”.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.